Pharmafile Logo

Glaucoma in perspective

- PMLiVE

Breakthrough Device status for novel blood filtering immunotherapy

Novel technology aims to reactivate immune system in cancer patients

Personas: a top tool for personalising pharma marketing campaigns

Healthcare customers are calling for greater personalisation in care from providers. Here, we explain why personas are the top tool for ensuring your brand meets this need efficiently and effectively.

Blue Latitude Health

- PMLiVE

What about me? Human centricity rather than patient centricity…

While the pace of change within the digital transformation brings both benefits and challenges, are HCPs being left behind?

Porterhouse Medical Group

- PMLiVE

Daily brief:  Trump fails to ruffle PBMs, pharma, Jowell leaves brain tumour research legacy

A rapid round-up of recent happenings, plus some key events taking place this week

Boehringer partners with Bactevo on drug discovery

Bactevo will use its TIME platform to identify small molecule lead compounds

Boehringer Ingelheim headquarters

Boehringer partners with Bactevo on drug discovery

Bactevo will use its TIME platform to identify small molecule lead compounds

- PMLiVE

Trio depart Reynolds-MacKenzie to set up new comms agency

Experienced trio have launched new company akt health communications

- PMLiVE

Trump pledges ‘total victory’ in war on drug prices

Despite rhetoric against pharma and PBMs, shares rise as markets shrug off threats to sector

Roche Basel Switzerland

Another IO knockback as Tecentriq combo fails phase III trial

The bulk of CRC patients with MSS currently look set to be excluded from cancer immunotherapy

- PMLiVE

AZ’s Fasenra hit by COPD trial failure

Results give advantage to respiratory rivals GSK

- PMLiVE

Despite FDA concerns, Akcea rare disease drug clears FDA panel

FDA now set to deliver final verdict by 30 August

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links